FDA Approves Zurzuvae (Zuranolone) – First Oral Treatment for Postpartum Depression
The FDA has approved Zurzuvae, a novel oral treatment for postpartum depression. Clinical studies have confirmed its effectiveness, but warnings include potential driving impairment and common side effects. This medication offers a new option beyond the previously available IV treatments.
https://scitechdaily.com/fda-approves-zurzuvae-zuranolone-first-oral-treatment-for-postpartum-depression/ #postpartum #depression #FDA #zurzuvae #oral #treatment